Related Experiment Video
Updated: Sep 19, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Dilated Cardiomyopathy May Be Associated With a Novel Mitochondrial tRNASer(AGY) Mutation
Yu Ding1, Xuejiao Yu2, Jian Xu1
1Department of Clinical Laboratory, Hangzhou First People's Hospital, Hangzhou, Zhejiang, China.
Insights
Mitochondrial tRNA mutations, including a novel m.12265A>G, are linked to dilated cardiomyopathy (DCM). These mutations impair mitochondrial function, affecting ATP production and increasing ROS, contributing to heart failure risk.
Area of Science:
- Genetics
- Mitochondrial Biology
- Cardiology
Background:
- Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
- Mitochondrial dysfunction, particularly due to mitochondrial transfer RNA (mt-tRNA) mutations, is increasingly implicated in DCM pathogenesis.
- The precise mechanisms linking mt-tRNA mutations to DCM remain incompletely understood.
Purpose of the Study:
- To identify and characterize novel mt-tRNA mutations associated with maternally inherited DCM.
- To investigate the functional consequences of identified mt-tRNA mutations on mitochondrial function.
- To elucidate the role of these mutations in the development of DCM.
Main Methods:
- Genetic analysis of a Chinese family with maternally inherited DCM to identify mutations.
- Characterization of a novel m.12265A>G mutation in mt-tRNASer(AGY) and a known m.5821G>A mutation in mt-tRNACys.
- Transmitochondrial cybrid studies to assess mitochondrial function in cells harboring the identified mutations.
Main Results:
- A novel m.12265A>G mutation in mt-tRNASer(AGY) and a known m.5821G>A mutation in mt-tRNACys were identified in a DCM pedigree.
- Mutations affected conserved regions of mt-tRNAs, including the acceptor arm and base pairing.
- Cybrid cells with these mutations exhibited impaired mitochondrial function: reduced ATP, membrane potential, mtDNA content, and respiratory complex activities.
- Mutant cells showed increased reactive oxygen species (ROS), calcium, and lactate levels.
Conclusions:
- The identified m.12265A>G and m.5821G>A mutations impair mitochondrial metabolism and function.
- These mitochondrial dysfunctions are implicated in the pathogenesis of dilated cardiomyopathy.
- The study expands the understanding of genotypic variations in mt-tRNA mutations linked to human diseases.
Abstract:
Dilated cardiomyopathy (DCM) is a serious public health problem that increases the risk of developing heart failure. Most recently, increasing evidence has shown that mitochondrial dysfunction caused by mitochondrial tRNA (mt-tRNA) mutations plays a putative role in the pathogenesis of this disease, despite its pathophysiology remaining poorly understood. In this study, a novel 12265A>G mutation in mt-tRNASer(AGY) was identified from a Chinese pedigree with maternally inherited DCM, together with a known mt-tRNACys 5821G>A mutation. Interestingly, the novel m.12265A>G mutation changed the well-conserved adenosine at Position 73 (A73) to guanine (G73) at the 3'-end of the mt-tRNASer(AGY) acceptor arm, while the G-to-A transition at 5821 occurred at the acceptor arm of mt-tRNACys, disrupting conserved base pairing (G6-C67). Transmitochondrial cybrid-based study demonstrated that cell lines with m.12265A>G and m.5821G>A mutations showed impaired mitochondrial functions, including significant reductions in mitochondrial ATP, membrane potential, NAD+/NADH ratio, mitochondrial DNA (mtDNA) content, mitochondrial transcription factor A (TFAM) mRNA expression levels, and respiratory chain enzyme Complex I and III activities, whereas the levels of reactive oxygen species (ROS), calcium ions (Ca2+), and lactate were enhanced in mutant cells compared to controls (p < 0.05). Thus, the m.12265A>G and m.5821G>A mutations may affect mt-tRNA metabolism and impair mitochondrial function, which is involved in DCM. Taken together, our study broadens the genotypic interpretation of mt-tRNA mutations linked to disease.
Related Concept Videos
Animal Mitochondrial Genetics
ATP Synthase: Mechanism
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Cardiomyopathy I: Introduction and Classification

